slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 18,421-18,450
Pages 1,935
Rows per page 30
Slide function
18,421-18,450 of 58,039
07
The slide uses a split-table format to contrast positive and negative performance contributors.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
08
The slide uses a table to demonstrate historical performance attribution.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
09
The slide includes a footnote clarifying the relationship between core funds and co-investment vehicles.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
22
The chart highlights the correlation between activist intervention/company news and stock price movement.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Solution & ApproachLoop · Pattern Hunter1 hit
31
The slide uses a simple list-based structure to compare historical results against forward-looking guidance.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Evidence & ProofLoop · Before After1 hit
36
The chart uses a dashed line to indicate the average cost basis of $16.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Evidence & ProofLoop · Before After1 hit
44
The chart highlights the starting price of $37 and the ending price of $103.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
58
The chart uses dashed lines to indicate the average cost basis for both stocks.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
69
The slide highlights a divergence between operational performance and valuation multiples.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
70
The slide uses a dashed line to indicate the average cost basis of $47 against the current price of $58.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor 1 hit
73
The slide defines 'Permanent' capital as the sum of GP and affiliates (4%), deferred incentive fees (3%), PSH NAV (33%), and PSH bond (8%).Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Impact & Next Steps1 hit
74
The slide provides a snapshot of the valuation gap between the market price and the NAV of the fund.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Impact & Next Steps1 hit
76
The chart highlights a significant disparity between broker-traded and exchange-traded volumes.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Impact & Next Steps1 hit
77
The slide highlights that broker trading volume is 2.3x exchange traded volume.Multiple holdings (Pershing Square portfolio) · Pershing Square
Activist deck Activist investor Beat · Impact & Next Steps1 hit
06
The chart highlights the significant outperformance of Pershing Square (567.1%) compared to the S&P 500 (135.3%) over the specified period.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor 1 hit
08
The slide uses a split-table format to contrast positive and negative performance contributors.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor 1 hit
09
Includes a footnote regarding HKD call options treatment.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor 1 hit
10
Includes a detailed disclaimer regarding the calculation of AUM and the inclusion of Air Products investments.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor 1 hit
14
The chart illustrates the convergence of price and NAV towards the end of the period.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor 1 hit
31
The chart highlights the correlation between Pershing Square's involvement and stock price movement.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor Beat · Solution1 hit
37
The slide uses a shaded region to transition to the next page and highlights the divergence between the purchase price ($196) and the current price ($89).Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor Beat · Evidence1 hit
47
The slide uses callout boxes to correlate specific corporate events with stock price movements.Pershing Square portfolio (multi-holding LP update: MDLZ, VRX, APD, ZTS, CP, QSR, HHC, PAH, FNMA/FMCC, HLF short) · William Ackman
Activist deck Activist investor Beat · EvidenceLoop · Cost Of Inaction1 hit
07
The slide uses a table to demonstrate the increasing reliance on the Chinese market.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster1 hit
18
This slide is likely from an activist presentation (Pershing Square/Ackman) critiquing Herbalife's business model by highlighting how 'credits' are framed as 'salary'.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster1 hit
27
The slide uses a structured table format to justify valuation inputs for an acquisition model.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Solution1 hit
28
The table models four scenarios based on annual M&A spend ($0bn, $5bn, $10bn, $20bn).Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Solution1 hit
43
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
45
The slide provides specific financial modeling parameters for Valeant and Salix, excluding future acquisitions.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
46
The slide details specific financial ratios (90% conversion, 4x leverage target, 5.75% cost of debt) and compares them to current/transaction-specific metrics.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
47
The slide details the logic for M&A spending caps and the subsequent use of excess debt capacity for share repurchases.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit